| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 11 |
| 1 | OCTREOTIDE ACETATE | 10 |
| 2 | CARBOPLATIN | 7 |
| 3 | PACLITAXEL | 6 |
| 4 | PACLITAXEL (AIBUMIN-BOUND) | 6 |
| 5 | ASPIRIN | 5 |
| 6 | ASPIRIN 325 MG | 5 |
| 7 | ASPIRIN 81 MG | 5 |
| 8 | ATEZOLIZUMAB | 5 |
| 9 | ERGOCALCIFEROL | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CHLORIDE 0.65% | 1 | 0.0007 |
| 1 | ZOLBETUXIMAB | 1 | 0.0007 |
| 2 | LORLATINIB | 3 | 0.0004 |
| 3 | FAMOTITINE | 1 | 0.0003 |
| 4 | GEFITINIB | 3 | 0.0003 |
| 5 | OCTREOTIDE ACETATE | 10 | 0.0003 |
| 6 | BRIGATINIB | 1 | 0.0003 |
| 7 | FLUOCINONIDE TOPICAL SOLUTION USP, 0.05% | 1 | 0.0002 |
| 8 | ERGOCALCIFEROL | 5 | 0.0002 |
| 9 | SORAFENIB | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 1 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 2 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 3 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 5 | Estrogen Receptor Antagonist [EPC] | 3 | 0.0001 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 11 | 0.0001 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 3 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 6 | 0.0000 |
| 9 | Iron Chelator [EPC] | 1 | 0.0000 |